1. 1. Friedman PS. Cyclosporin A therapy: Immunological and therapeutic implications. In: Burgdorf W, Katz S (eds). Dermatology, Progress and Perspectives. Park Ridge: The Parthenon Publishing Group, 1993; 566-8.
2. 2. Neuber K , Schwartz I , Itschert G , Dieck AT. Treatment of atopic eczema with oral mycophenolate mofetil. Br. J. Dermatol. 2000; 143: 385-91.
3. 3. Reinhold U , Wehrmann W , Kukel S , Kreysel HW. Recombinant interferon-gamma in severe atopic dermatitis. Lancet 1990; 335: 1282.
4. 4. Shupack JL , Silverman Kitchin JE , Stiller MJ , Webster GF. Cytotoxic and antimetabolic agents. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB (eds). Fitzpatrick’s Dermatology in General Medicine. 5th edn. New York: McGraw Hill, 1999; 2802-4.
5. Azathioprine in dermatology: A survey of current practice in the U.K.;Tan;Br. J. Dermatol.,1997